Ernest R Vina1, Cristian Quinones2, Leslie R M Hausmann3, Said A Ibrahim4, C Kent Kwoh5. 1. E.R. Vina, MD, MS, Associate Professor of Medicine, C.K. Kwoh, MD, Professor of Medicine, Division of Rheumatology, University of Arizona School of Medicine, Tucson, Arizona; evina@email.arizona.edu. 2. C.Q. Quinones, BS, University of Arizona Arthritis Center, Tucson, Arizona. 3. L.R. Hausmann, PhD, Core Investigator, Veterans Affairs Pittsburgh Healthcare System, and Associate Professor of Medicine, Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 4. S. Ibrahim, Professor, Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York, USA. 5. E.R. Vina, MD, MS, Associate Professor of Medicine, C.K. Kwoh, MD, Professor of Medicine, Division of Rheumatology, University of Arizona School of Medicine, Tucson, Arizona.
Abstract
OBJECTIVE: While opioids are known to cause unintended adverse effects, they are being utilized by a number of patients with osteoarthritis (OA). The aim of this study was to evaluate the association of patient familiarity and perceptions regarding efficacy and risks with opioid medication use for OA. METHODS: A total of 362 adults with knee and/or hip OA were surveyed in this cross-sectional study. Patients' familiarity with and perceptions of benefits/risks of opioid medications were measured to evaluate potential associations with the utilization of opioid medications for OA within the last 6 months. Logistic regression models were adjusted for sociodemographic and clinical variables. RESULTS: In this sample, 28.7% (100/349) reported use of an opioid medication for OA-related symptoms in the last 6 months. Those who were on an opioid medication, compared to those who were not, were younger (mean age 62.5 vs 64.8 yrs), were more likely to have a high school education or lower (48.0% vs 35.3%), and had higher mean depression (Patient Health Questionnaire [PHQ]-8 7.2 vs 4.9) and OA-related pain (Western Ontario and McMaster Universities Arthritis Index [WOMAC] 54.8 vs 46.8) scores. After adjustment for sociodemographic and clinical variables, the following were associated with opioid medication use: higher perception of medication benefit (OR 1.68, 95% CI 1.18-2.41), lower perception of medication risk (OR 0.67, 95% CI 0.51-0.88), and having family or friends who received the medication for OA (OR 3.88, 95% CI 1.88-8.02). CONCLUSION: Among adults with knee/hip OA, opioid use was associated with being familiar with the treatment, as well as believing that the medication was beneficial and low-risk.
OBJECTIVE: While opioids are known to cause unintended adverse effects, they are being utilized by a number of patients with osteoarthritis (OA). The aim of this study was to evaluate the association of patient familiarity and perceptions regarding efficacy and risks with opioid medication use for OA. METHODS: A total of 362 adults with knee and/or hip OA were surveyed in this cross-sectional study. Patients' familiarity with and perceptions of benefits/risks of opioid medications were measured to evaluate potential associations with the utilization of opioid medications for OA within the last 6 months. Logistic regression models were adjusted for sociodemographic and clinical variables. RESULTS: In this sample, 28.7% (100/349) reported use of an opioid medication for OA-related symptoms in the last 6 months. Those who were on an opioid medication, compared to those who were not, were younger (mean age 62.5 vs 64.8 yrs), were more likely to have a high school education or lower (48.0% vs 35.3%), and had higher mean depression (Patient Health Questionnaire [PHQ]-8 7.2 vs 4.9) and OA-related pain (Western Ontario and McMaster Universities Arthritis Index [WOMAC] 54.8 vs 46.8) scores. After adjustment for sociodemographic and clinical variables, the following were associated with opioid medication use: higher perception of medication benefit (OR 1.68, 95% CI 1.18-2.41), lower perception of medication risk (OR 0.67, 95% CI 0.51-0.88), and having family or friends who received the medication for OA (OR 3.88, 95% CI 1.88-8.02). CONCLUSION: Among adults with knee/hip OA, opioid use was associated with being familiar with the treatment, as well as believing that the medication was beneficial and low-risk.
Authors: Leslie R M Hausmann; Maria Mor; Barbara H Hanusa; Susan Zickmund; Peter Z Cohen; Richard Grant; Denise M Kresevic; Howard S Gordon; Bruce S Ling; C Kent Kwoh; Said A Ibrahim Journal: J Gen Intern Med Date: 2010-05-28 Impact factor: 5.128
Authors: Meghana Yajnik; Jonay N Hill; Oluwatobi O Hunter; Steven K Howard; T Edward Kim; T Kyle Harrison; Edward R Mariano Journal: Patient Educ Couns Date: 2018-09-05
Authors: Elizabeth A Wright; Jeffrey N Katz; Stanley Abrams; Daniel H Solomon; Elena Losina Journal: Arthritis Care Res (Hoboken) Date: 2014-10 Impact factor: 4.794
Authors: R Altman; G Alarcón; D Appelrouth; D Bloch; D Borenstein; K Brandt; C Brown; T D Cooke; W Daniel; D Feldman Journal: Arthritis Rheum Date: 1991-05
Authors: Zachary A Marcum; Subashan Perera; Julie M Donohue; Robert M Boudreau; Anne B Newman; Christine M Ruby; Stephanie A Studenski; C Kent Kwoh; Eleanor M Simonsick; Doug C Bauer; Suzanne Satterfield; Joseph T Hanlon Journal: Pain Med Date: 2011-10-12 Impact factor: 3.750
Authors: David E DeMik; Nicholas A Bedard; S Blake Dowdle; Robert A Burnett; Michael A McHugh; John J Callaghan Journal: J Arthroplasty Date: 2017-07-25 Impact factor: 4.757
Authors: Ernest R Vina; Philip H Tsoukas; Shahrzad Abdollahi; Nidhi Mody; Stephanie C Roth; Albert H Redford; C Kent Kwoh Journal: Ther Adv Musculoskelet Dis Date: 2022-06-30 Impact factor: 3.625